Elma Meershoek‐Klein Kranenbarg - Researcher Profile

Publications

3 shown

Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

H.H. Hartgrink , C.J.H. van de Velde , Hein Putter +16 more

Purpose The extent of lymph node dissection appropriate for gastric cancer is still under debate. We have conducted a randomized trial to compare the results of a limited (D1) a...

2004 Journal of Clinical Oncology 919 citations

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer , Esmée A. Dijkstra , Boudewijn van Etten +97 more

Systemic relapses remain a major problem in locally advanced rectal cancer. Using short-course radiotherapy followed by chemotherapy and delayed surgery, the Rectal cancer And P...

2020 The Lancet Oncology 1432 citations

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

H.H. Hartgrink , Cornelis J.�H. van de Velde , Hein Putter +7 more

2004 European Journal of Surgical Oncology 198 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 2,549
Institution: Amsterdam UMC Location University of Amsterdam

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1750-2221

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.